Phospho-Serine-118 Estrogen Receptor-α Expression Is Associated with Better Disease Outcome in Women Treated with Tamoxifen
- 1 September 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (17) , 5902-5906
- https://doi.org/10.1158/1078-0432.ccr-04-0191
Abstract
Purpose: The purpose of this research was to determine whether estrogen receptor α specifically phosphorylated at Ser118 is associated with clinical outcome in primary breast tumors from estrogen receptor-positive and node-negative breast cancer patients.Keywords
This publication has 11 references indexed in Scilit:
- Phospho-Serine-118 Estrogen Receptor-α Detection in Human Breast Tumors in Vivo Clinical Cancer Research, 2004
- Antiestrogen resistance in breast cancer and the role of estrogen receptor signalingOncogene, 2003
- Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer DatabasesJournal of Clinical Oncology, 2003
- Is Tamoxifen the Rosetta Stone for Breast Cancer?JNCI Journal of the National Cancer Institute, 2003
- Estrogen receptor phosphorylationSteroids, 2003
- Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antiseraOncogene, 2002
- Activation of Estrogen Receptor α by S118 Phosphorylation Involves a Ligand-Dependent Interaction with TFIIH and Participation of CDK7Molecular Cell, 2000
- Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast CancerJournal of Clinical Oncology, 1999
- Tamoxifen in the Treatment of Breast CancerNew England Journal of Medicine, 1998
- Hyperexpression of mitogen-activated protein kinase in human breast cancer.Journal of Clinical Investigation, 1997